QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

CRL

QT76Charles River Laboratories International, Inc.
NYSE·Healthcare·Medical - Diagnostics & Research·USA
Latest market price
185.00
+2.66+1.46%
OverviewShort InterestFilings
CRLQT76Charles River Laboratories International, Inc.·NYSE
OverviewShort InterestFilings
185.00+1.46%
TA
Loading chart...
Screen all →
TMO+0.63%$464.61DHR-0.33%$177.17IDXX+2.93%$562.09A+2.20%$127.06NTRA+2.19%$231.41IQV-1.70%$167.77ILMN+1.79%$161.93WAT-0.44%$355.44
Snapshot
Index-P/E-EPS (ttm)-3.76
Insider Own1.50%
Shs Outstand48.17M
Perf Week-1.63%
Market Cap8.78BForward P/E14.99EPS next Y12.34Insider Trans0.00%Shs Float-Perf Month21.37%
Enterprise Value11.65BPEG0.48EPS next Q2.72Inst Own-Short Float-Perf Quarter20.88%
Income-181806110.00P/S2.18EPS this Y395.05%Inst Trans-Short Ratio-Perf Half Y-5.24%
Sales4.03BP/B3.04EPS next Y11.22%ROA-2.39%Short Interest-Perf YTD-7.26%
Book/sh62.03P/C14.70EPS next 5Y8.37%ROE-5.74%52W High228.88 -19.17%Perf Year27.54%
Cash/sh3.99P/FCF22.45EPS past 3/5Y-ROIC7.14%52W Low143.06 29.32%Perf 3Y-
Dividend Est.-EV/EBITDA40.09Sales past 3/5Y0.33% 6.55%Gross Margin31.86%Volatility2.17% 2.97%Perf 5Y-
Dividend TTM-EV/Sales2.89EPS Y/Y TTM4900.00%Oper. Margin11.77%ATR (14)7.63Perf 10Y-
Dividend Ex-Date-Quick Ratio1.03Sales Y/Y TTM-0.57%Profit Margin-4.59%RSI (14)56.55Recom2.11
Dividend Gr. 3/5Y-Current Ratio1.36EPS Q/Q-11.97%SMA203.21%Beta1.36Target Price214.14
Payout0.00%Debt/Eq1.04Sales Q/Q1.22%SMA505.98%Rel Volume1.38Prev Close182.34
Employees18,700LT Debt/Eq0.94EarningsAug 05SMA2003.92%Avg Volume850.64KPrice185.00
IPO DateJun 23, 2000Option/ShortYes / YesEPS/Sales Surpr.5.10% 1.94%Net Debt/EBITDA9.86Volume1,170,070Change1.46%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-17-26UpgradeMorgan StanleyEqual Weight → Overweight$185 → $220
May-29-26UpgradeCLSAHold → Outperform$219
May-08-26ReiteratedRobert W. Baird$200 → $213
May-08-26ReiteratedEvercore ISI$200 → $220
May-08-26ReiteratedMizuho Securities$175 → $192
May-08-26ReiteratedBarclaysOverweight$210 → $220
Apr-14-26InitiatedRBC CapitalOutperform$215
Apr-14-26ReiteratedBarclaysOverweight$200 → $210
Feb-20-26ReiteratedMizuho Securities$215 → $175
Feb-19-26ReiteratedRobert W. Baird$231 → $193
Latest News
Jun-18-26
Jun-18-2612:00PM
Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing ExpertiseYahoo
03:17AM
Morgan Stanley Upgrades Charles River Laboratories International (CRL)Fintel
Jun-17-26
Jun-17-2603:22PM
Stocks Mixed Ahead of FOMC Meeting ResultsYahoo
01:47PM
Lyft upgraded, Leidos downgraded: Wall Street's top analyst callsYahoo
01:13PM
Morgan Stanley favors Charles River Over IQVIA in CRO sector resetYahoo
09:08AM
This Charles River Analyst Turns Bullish; Here Are Top 4 Upgrades For WednesdayBenzinga
09:05AM
Delta Air Lines To Rally Around 12%? Here Are 10 Top Analyst Forecasts For WednesdayBenzinga
08:55AM
Morgan Stanley Upgrades Charles River to Overweight, Raises Price Target to $220Benzinga
Jun-16-26
Jun-16-2610:57AM
1 S&P 500 Stock on Our Buy List and 2 We Brush OffYahoo
Jun-15-26
Jun-15-2603:40PM
LH vs. CRL: Which Stock Is the Better Value Option?Yahoo
Jun-12-26
Jun-12-2603:26PM
Charles River Labs (CRL) Pulled Back Due to AI Disruption FearsYahoo
Jun-10-26
Jun-10-2602:41PM
Reasons Why You Should Hold Charles River Stock in Your PortfolioYahoo
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/27/2025
FY 2024
12/28/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue4,0274,0154,050
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A2,7442,7902,718
Gross Profit1,2831,2261,332
Selling, General and Administrative Excl. Other717743751
Research and Development
000
Other Operating Expense92-25353
Operating Income474508227
Interest Expense106107126
Unusual Expense
———
Non-Operating Income (Expense)5345008
Net Income Before Taxes-166-10093
Income Taxes184368
Consolidated Net Income-186-14410
Net Income From Continuing Operations-182-14225
Net Income-186-14410
EPS (Recurring)-3.75-2.910.20
EPS (Basic, Before Extraordinaries)-3.75-2.910.20
EPS (Diluted)-3.76-2.910.20
EBITDA291411581
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio2.252.54—
Gross Margin31.8630.5432.89
Operating Margin11.7712.655.60
Net Margin-4.62-3.590.25
Shares Outstanding495051
Market Capitalization9,06510,183—
Operating Lease Expense
———
Insider Trading Volume
$211.80$197.85$183.90$169.94$155.99● Close Price0.00K62.90K125.79K188.69K251.58KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
LaPlume Joseph WEVP, Corp Strategy & DevelopMar 03 '26Buy174.54254,36427,448Mar 04 12:00 AM
LaPlume Joseph WEVP, Corp Strategy & DevelopAug 22 '25Sale163.7240065,48823,716Jan 20 12:00 AM
LaPlume Joseph WEVP, Corp Strategy & DevelopAug 18 '25Sale157.60800126,08024,116Aug 20 12:00 AM
LaPlume Joseph WEVP, Corp Strategy & DevelopAug 07 '25Sale150.0440060,01624,916Aug 08 12:00 AM
MASSARO GEORGEDirectorMay 15 '25Sale137.5714019,2605,575May 16 12:00 AM
MASSARO GEORGEDirectorMay 14 '25Sale140.7414019,7025,715May 15 12:00 AM
LaPlume Joseph WEVP, Corp Strategy & DevelopMay 13 '25Sale145.4150072,70519,513May 15 12:00 AM
FOSTER JAMES CChairman, President and CEOFeb 20 '25Buy165.016,0751,002,436183,639Feb 21 12:00 AM
Girshick BirgitCorporate Executive VP & COOFeb 20 '25Buy164.631,514249,25055,058Feb 21 12:00 AM
LaPlume Joseph WEVP, Corp Strategy & DevelopFeb 20 '25Sale162.504,400715,00020,013Feb 21 12:00 AM
WALLMAN RICHARD FDirectorNov 07 '24Sale216.177,6211,647,4180Nov 12 12:00 AM
LaPlume Joseph WEVP, Corp Strategy & DevelopAug 08 '24Sale199.361,780354,86122,521Aug 12 12:00 AM
FOSTER JAMES CChairman, President and CEOAug 01 '24Sale250.0025,0006,250,000188,251Aug 05 12:00 AM
Knell Michael GunnarCSVP&Chief Accounting OfficerMar 08 '24Option Exercise223.591,616361,3218,633May 29 12:00 AM
Knell Michael GunnarCSVP&Chief Accounting OfficerMar 08 '24Sale267.521,616432,3127,024May 29 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR